2017 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
2022 (v1)Publication
Carbapenemase-producing Enterobacterales (CPE) represent a major cause of difficult-to-treat infections worldwide. The novel β-lactam/β-lactamase inhibitor combinations (BLICs), including ceftazidime/avibactam (CZA), meropenem/vaborbactam (MVB), and imipenem/relebactam (IMR), represented a breakthrough to treat some CPE infections. However,...
Uploaded on: February 14, 2024 -
2018 (v1)Publication
This study aimed to assess the predictors of acute kidney injury (AKI) during colistin therapy in a cohort of patients with bloodstream infections (BSI) due to colistin-susceptible Gram-negative bacteria, focusing on the role of serum albumin levels. The study consisted of two parts: (1) a multicentre retrospective clinical study to assess the...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
The spread of resistance to vancomycin and other last-resort drugs inEnterococcusspp. remains of concern. In Italy, surveillance data for enterococcal bloodstream isolates in humans are scant. The aim of our study was to assess the incidence trends of bacteremias due toEnterococcusspecies and their prevalence trends of antimicrobial resistance....
Uploaded on: February 14, 2024